Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Blood 02. April 2026
Search
medline.ch
Blood
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8345  Previews Next
   
   Articles 1 - 20 / 166892  
   
Hodgkinoid histiocytosis, a distinctive histiocytic/dendritic cell disorder clinically mimicking drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
J Clin Exp Hematop
Oyama Y, Kubota-Furukawa R, Saito K, Nishikawa T, Takano K, Izumi T, Yoshimura K, Shiota S, Hatano Y, Nishida H, Takeshita M, Daa T.
PMID: 41922228 [PubMed - indexed for MEDLINE]


CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy.
J Clin Exp Hematop
Moriwaki K, Tatetsu H, Higuchi Y, Nakamura T, Naito A, Yamada A, Shichijo T, Tokunaga K, Gushima R, Shiota T, Mikami Y, Nosaka K, Tanaka Y, Karube K, Yasunaga JI.
PMID: 41922227 [PubMed - indexed for MEDLINE]


CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.
J Clin Exp Hematop
Sawada K, Takahashi T, Fukumura Y, Onagi H, Ashizawa K, Yamashita T, Yamamoto W, Takayanagi N, Adachi A, Kashimura M, Tabayashi T, Tamaru JI, Higashi M, Momose S.
PMID: 41922226 [PubMed - indexed for MEDLINE]


Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD study.
ESMO Open
Trotman J, Bouabdallah K, Bijou F, , de Oliveira AC, Song Y, Kingsley EC, Flowers CR, Liao S, Huang S, Shah N, Dumartin L, Zinzani PL.
PMID: 41922143 [PubMed - as supplied by publisher]


Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia.
Biomed Pharmacother
Silva SLR, Barbosa GADC, Rios JVB, Bezerra DP.
PMID: 41922112 [PubMed - as supplied by publisher]


CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review.
J Natl Compr Canc Netw
Al-Mashdali AF, Abdelraof MO, Mukhtar RM, Dali SA, Mahfouz Y, Mohamed SF.
PMID: 41921534 [PubMed - in process]


The APLC expert consensus recommendations on the management of chronic lymphocytic leukaemia in Asia.
Ann Acad Med Singap
Ong SY, Chan T, Tse EWC, Mulligan S, Bee PC, Izutsu K, Kim JS, Ko BS, Li J, Ng SC, Norasetthada L, Qiu L, Rattanathammethee T, Tam C, Yi S, Zhu H, Goh YT.
PMID: 41920799 [PubMed - indexed for MEDLINE]


Emerging Therapeutic Strategies in Cutaneous T-Cell Lymphoma: A Comprehensive Review of Clinical Trials.
Am J Clin Dermatol
Sacknovitz Y, Ma R, Bear CM, Zhou MH, Kent JA, Geskin LJ.
PMID: 41920459 [PubMed - as supplied by publisher]


"Expression of a recombinant chimeric capsid-nucleocapsid protein from bovine leukemia virus genotype 1 for the diagnosis of enzootic bovine leukosis".
Vet Res Commun
Sánchez Gasca JH, Cuevas Romero JS, Cerriteño Sánchez JL, Rodríguez-Murillo C, Acevedo-Jiménez GE, Ramírez Álvarez H.
PMID: 41920455 [PubMed - in process]


Evolution of the European LeukemiaNet recommendations for chronic myeloid leukemia.
Expert Rev Hematol
Yolcu A, Haznedaroglu IC.
PMID: 41920307 [PubMed - as supplied by publisher]


Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma.
J Chemother
Annibali O, Bancone C, Tomarchio V, Colafranceschi G, Tafuri M, Del Principe I, Mele M, Fazio F, Rigacci L.
PMID: 41919607 [PubMed - as supplied by publisher]


Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial".
Haematologica
Schlenk RF, Montesinos P, Kim HJ, Romero-Aguilar A, Vrhovac R, Patkowska E, , Wang PN, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP.
PMID: 41919560 [PubMed - in process]


Postoperative complications in patients with chemotherapy-induced acute myeloid leukemia (Review).
Oncol Lett
Lin CH, Liu HT, Hsieh CH.
PMID: 41918812 [PubMed]


LY-H as a potential screening biomarker for lymphocyte activation in peripheral blood.
Front Immunol
Qin KC, Yang CH, Zhang YH, Wang XY, Jin PP, Ding N.
PMID: 41918755 [PubMed - indexed for MEDLINE]


A 64-Year-Old Man Presenting With Diplopia and Right Orbital Swelling Due to Mucosa-Associated Lymphoid Tissue Lymphoma.
Am J Case Rep
Altamimi LM, Algahtani FH, Alharbi MG, Alakeel FS, Alhentti BA.
PMID: 41918141 [PubMed - indexed for MEDLINE]


Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center study.
Radiat Oncol
Stolz SM, von Wachter C, Willmann J, Rieger MJ, Kreutmair S, Mamozai W, Rösler W, Hockl P, Ahmadsei M, Christ SM, Motisi L, Guckenberger M, Schneidawind D, Mayinger M.
PMID: 41917971 [PubMed - as supplied by publisher]


Postmarketing surveillance study of asciminib in patients with resistant/intolerant chronic myeloid leukemia in Japan.
Int J Hematol
Yamaguchi K, Aoki M, Osako R.
PMID: 41917309 [PubMed - as supplied by publisher]


EPR26-321: Sorafenib Plus Intensive Chemotherapy in Newly Diagnosed Adults With Acute Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Vatvani AD, Nada R, Altamirano MFA, Damara I, Oktrian O, Yausep OE, Shabarek N.
PMID: 41916363 [PubMed - in process]


HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia).
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41916353 [PubMed - in process]


Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.
Blood Adv
Furman RR, Wierda WG, Patten PE, Chaves JM, Brown JR, Munir T, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos JC, Patel K, Woyach JA, de Borja M, Wang MH, Jain N, O'Brien SM MD, Byrd JC.
PMID: 41915892 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 166892    Page 1 of 8345  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1